Literature DB >> 20400773

The determination of patient dose from (18)F-FDG PET/CT examination.

K Khamwan1, A Krisanachinda, P Pasawang.   

Abstract

The use of positron emission tomography/computed tomography (PET/CT) system has heightened the need for medical diagnosis. However, the patient dose is increasing in comparison to whole-body PET/CT dose. The aim of this study is to determine the patient effective dose in 35 oncology Thai patients with the age range of 28-60 y from PET scan using [fluorine-18]-fluoro-2-deoxy-D-glucose and from CT scan. Cumulated activity and residence time of various organs were calculated from time-activity curves by using S-value based on the body mass. Mean organ absorbed dose and the effective dose from CT scan were calculated using the Medical Internal Radiation Dosimetry method and Monte Carlo simulation, respectively. The average whole-body effective doses from PET and CT were 4.40 + or - 0.61 and 14.45 + or - 2.82 mSv, respectively, resulting in the total patient dose of 18.85 mSv. This can be used as the reference dose in Thai patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400773     DOI: 10.1093/rpd/ncq140

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  15 in total

1.  Exposing exposure: enhancing patient safety through automated data mining of nuclear medicine reports for quality assurance and organ dose monitoring.

Authors:  Ichiro Ikuta; Aaron Sodickson; Elliot J Wasser; Graham I Warden; Victor H Gerbaudo; Ramin Khorasani
Journal:  Radiology       Date:  2012-05-24       Impact factor: 11.105

2.  Finding sensitive parameters in internal dose calculations for radiopharmaceuticals commonly used in clinical nuclear medicine.

Authors:  Vladimir Spielmann; Wei Bo Li; Maria Zankl
Journal:  Radiat Environ Biophys       Date:  2018-06-29       Impact factor: 1.925

3.  CT dose modulation using automatic exposure control in whole-body PET/CT: effects of scout imaging direction and arm positioning.

Authors:  Yusuke Inoue; Kazunori Nagahara; Hiroko Kudo; Hiroyasu Itoh
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

4.  Estimation of kidneys and urinary bladder doses based on the region of interest in 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography examination: a preliminary study.

Authors:  Farida Aimi Mustapha; Farahnaz Ahmad Anwar Bashah; Ihsan M Yassin; Ahmad Saad Fathinul Fikri; Abdul Jalil Nordin; Hairil Rashmizal Abdul Razak
Journal:  Quant Imaging Med Surg       Date:  2017-06

5.  Does the Incremental Value of 123I-Metaiodobenzylguanidine SPECT/CT over Planar Imaging Justify the Increase in Radiation Exposure?

Authors:  Dorra Ben-Sellem; Naima Ben-Rejeb
Journal:  Nucl Med Mol Imaging       Date:  2021-07-07

6.  Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.

Authors:  Brian Quinn; Zak Dauer; Neeta Pandit-Taskar; Heiko Schoder; Lawrence T Dauer
Journal:  BMC Med Imaging       Date:  2016-06-18       Impact factor: 1.930

7.  Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.

Authors:  Dan Liu; Pek-Lan Khong; Yiming Gao; Usman Mahmood; Brian Quinn; Jean St Germain; X George Xu; Lawrence T Dauer
Journal:  J Nucl Med       Date:  2016-01-28       Impact factor: 10.057

8.  Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinations.

Authors:  Matthias S May; Michael Brand; Wolfgang Wuest; Katharina Anders; Torsten Kuwert; Olaf Prante; Daniela Schmidt; Simone Maschauer; Richard C Semelka; Michael Uder; Michael A Kuefner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-02       Impact factor: 9.236

Review 9.  Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Authors:  Uta Eberlein; Jörn Hendrik Bröer; Charlot Vandevoorde; Paula Santos; Manuel Bardiès; Klaus Bacher; Dietmar Nosske; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-30       Impact factor: 9.236

10.  Human Radiation Dosimetry for Orally and Intravenously Administered 18F-FDG.

Authors:  Senthamizhchelvan Srinivasan; John P Crandall; Prateek Gajwani; George Sgouros; Esther Mena; Martin A Lodge; Richard L Wahl
Journal:  J Nucl Med       Date:  2019-10-18       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.